1. Prognostic factor analysis in 325 patients with Graves’ disease treated with radioiodine therapy
   Danrong Yang et al, 2018, Nuclear Medicine Communications CrossRef
2. Radiosensitivity-related postirradiation hypothyroidism in Graves’ disease patients
   Xi Jia et al, 2019, Hormones CrossRef
3. Analysis of the p53 pathway in peripheral blood of retinoblastoma patients; potential biomarkers
   Mayra Martínez-Sánchez et al, 2020, PLoS ONE CrossRef
4. Enhanced γ-H2AX Foci Frequency and Altered Gene Expression in Participants Exposed to Ionizing Radiation During I-131 Nuclear Medicine Procedures
   Shruti Hariharan et al, 2024, Nucl Med Mol Imaging CrossRef
5. Predictive factors influencing hypothyroidism following the radioactive iodine treatment of Graves’ disease in different periods
   Aomei Zhao et al, 2024, Sci Rep CrossRef